HEATON LARRY C II 4

What Happened

• Larry C. Heaton II, CEO and director of Zomedica Corp. (TSSI), reported an open-market/private purchase of 250,000 shares on May 8, 2026.
• The shares were acquired at $0.11 per share for a total reported cost of $27,500. This was a purchase (P) reported on Form 4, which is typically viewed as a more informative signal than routine sales but does not by itself explain motivation.

Key Details

• Transaction date: 2026-05-08; Price: $0.11 per share; Shares bought: 250,000; Total value: $27,500.
• Transaction code: P (purchase).
• Filing date: 2026-05-08 — the Form 4 was filed the same day the report covers (appears timely).
• Shares owned after transaction: not specified in the provided filing excerpt.
• No 10b5-1 plan, tax withholding, or other footnotes were noted in the reported transaction details provided here.

Context

• Insider purchases can indicate the insider is adding to their stake, but they don’t guarantee future stock performance. Retail investors often pay more attention to buys than sells because purchases represent a direct personal investment by insiders.
• This was a relatively small-dollar purchase ($27.5k) for an executive; interpret size accordingly and consider it alongside other filings, company news, and fundamentals.